The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)
- Author
- AGGARWAL, Rahul1 ; HALABI, Susan2 ; CARDUCCI, Michael11 ; SMALL, Eric J12 ; KEVIN KELLY, William3 ; GEORGE, Daniel4 ; MAHONEY, John F5 ; MILLARD, Frederick6 ; STADLER, Walter M7 ; MORRIS, Michael J8 ; KANTOFF, Philip9 ; MONK, J. Paul10
[1] Division of Hematology/Oncology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
[2] Department of Biostatistics and Bioinformatics and Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina, United States
[3] Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
[4] Department of Medicine-Oncology, Duke University Medical Center, Durham, North Carolina, United States
[5] Carolinas Medical Center, Charlotte, North Carolina, United States
[6] Division of Hematology-Oncology, University of California San Diego, San Diego, California, United States
[7] Section of Hematology, Oncology, University of Chicago, Chicago, Illinois, United States
[8] Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
[9] Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, United States
[10] Department of Internal Medicine, The Ohio State University, Columbus, Ohio, United States
[11] Department of Oncology and Urology, The Johns Hopkins University, Baltimore, Maryland, United States
[12] Department of Medicine and Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Alliance for Clinical Trials in Oncology, United States - Source
Cancer. 2013, Vol 119, Num 20, pp 3636-3643, 8 p ; ref : 25 ref
- CODEN
- CANCAR
- ISSN
- 0008-543X
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Blackwell, Hoboken, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- androgen antagonists chemotherapy ketoconazole prostatic neoplasms steroid 17-alpha-hydroxylase
- Keyword (fr)
- Androgène Antagoniste Anticancéreux Antifongique Cancer de la prostate Cancérologie Chimiothérapie Docétaxel Essai clinique phase III Essai clinique Evolution Homme Hydroxylase Inhibiteur Inhibition Kétoconazole Métastase Pronostic Randomisation Résistance Rétrospective Stade avancé Stéroïde Traitement Tumeur de la prostate Antimitotique Cancer Dérivé de l'imidazole Dérivé du taxane Enzyme Hormone stéroïde sexuelle Oxidoreductases Pathologie de l'appareil génital mâle Pathologie de l'appareil urinaire Pathologie de la prostate Tumeur maligne
- Keyword (en)
- Androgen Antagonist Antineoplastic agent Antifungal agent Prostate cancer Cancerology Chemotherapy Docetaxel Phase III trial Clinical trial Evolution Human Hydroxylase Inhibitor Inhibition Ketoconazole Metastasis Prognosis Randomization Resistance Retrospective Advanced stage Steroid Treatment Prostate tumor Antimitotic Cancer Imidazole derivatives Taxane derivatives Enzyme Sex steroid hormone Oxidoreductases Male genital diseases Urinary system disease Prostate disease Malignant tumor
- Keyword (es)
- Andrógeno Antagonista Anticanceroso Antifúngico Cáncer de la próstata Cancerología Quimioterapia Docetaxel Ensayo clínico fase III Ensayo clínico Evolución Hombre Hydroxylase Inhibidor Inhibición Ketoconazol Metástasis Pronóstico Aleatorización Resistencia Retrospectiva Estadio avanzado Esteroide Tratamiento Tumor prostata Antimitótico Cáncer Imidazol derivado Taxane derivado Enzima Hormona esteroide sexual Oxidoreductases Aparato genital macho patología Aparato urinario patología Prostata patología Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D02 Urinary tract. Prostate gland
- Discipline
- Nephrology. Urinary tract diseases Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27788210
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/cncr.28285 
https://dx.doi.org/10.1002/cncr.28285
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.28285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"3636\";s:8:\"\u0000*\u0000epage\";s:4:\"3643\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"AGGARWAL\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rahul\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"HALABI, Susan\";i:1;s:17:\"CARDUCCI, Michael\";i:2;s:13:\"SMALL, Eric J\";i:3;s:20:\"KEVIN KELLY, William\";i:4;s:14:\"GEORGE, Daniel\";i:5;s:15:\"MAHONEY, John F\";i:6;s:18:\"MILLARD, Frederick\";i:7;s:17:\"STADLER, Walter M\";i:8;s:17:\"MORRIS, Michael J\";i:9;s:15:\"KANTOFF, Philip\";i:10;s:13:\"MONK, J. Paul\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.28285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"3636\";s:8:\"\u0000*\u0000epage\";s:4:\"3643\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"AGGARWAL\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rahul\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"HALABI, Susan\";i:1;s:17:\"CARDUCCI, Michael\";i:2;s:13:\"SMALL, Eric J\";i:3;s:20:\"KEVIN KELLY, William\";i:4;s:14:\"GEORGE, Daniel\";i:5;s:15:\"MAHONEY, John F\";i:6;s:18:\"MILLARD, Frederick\";i:7;s:17:\"STADLER, Walter M\";i:8;s:17:\"MORRIS, Michael J\";i:9;s:15:\"KANTOFF, Philip\";i:10;s:13:\"MONK, J. Paul\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.28285\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.28285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"3636\";s:8:\"\u0000*\u0000epage\";s:4:\"3643\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"AGGARWAL\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rahul\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"HALABI, Susan\";i:1;s:17:\"CARDUCCI, Michael\";i:2;s:13:\"SMALL, Eric J\";i:3;s:20:\"KEVIN KELLY, William\";i:4;s:14:\"GEORGE, Daniel\";i:5;s:15:\"MAHONEY, John F\";i:6;s:18:\"MILLARD, Frederick\";i:7;s:17:\"STADLER, Walter M\";i:8;s:17:\"MORRIS, Michael J\";i:9;s:15:\"KANTOFF, Philip\";i:10;s:13:\"MONK, J. Paul\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:18:\"10.1002\/cncr.28285\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"119\";s:8:\"\u0000*\u0000issue\";s:2:\"20\";s:8:\"\u0000*\u0000spage\";s:4:\"3636\";s:8:\"\u0000*\u0000epage\";s:4:\"3643\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"AGGARWAL\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Rahul\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"HALABI, Susan\";i:1;s:17:\"CARDUCCI, Michael\";i:2;s:13:\"SMALL, Eric J\";i:3;s:20:\"KEVIN KELLY, William\";i:4;s:14:\"GEORGE, Daniel\";i:5;s:15:\"MAHONEY, John F\";i:6;s:18:\"MILLARD, Frederick\";i:7;s:17:\"STADLER, Walter M\";i:8;s:17:\"MORRIS, Michael J\";i:9;s:15:\"KANTOFF, Philip\";i:10;s:13:\"MONK, J. Paul\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:264:\"The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:15:\"Wiley-Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
